No Data
Zhongtai: All-weather application of AI smart glasses is expected to scale from 1 to 10.
The current development stage of the AI Asia Vets glasses sector can be compared to that of smartwatches in 2014, and significant growth is expected in the future. A neutral estimate suggests that the Global/China smart glasses market size could reach 435/77.5 billion yuan, indicating substantial growth potential.
Impulse(Qingdao)Health Tech (002899.SZ): Successfully developed self-lubricating simulated ice rinks, indoor skiing simulators, and other snow series products.
Gelonghui reported on December 18 that Impulse(Qingdao)Health Tech (002899.SZ) stated on the investor interaction platform that the company has been deeply engaged in the field of ice and snow sports for many years, possessing rich practical experience. Many years ago, in response to the national call to vigorously develop ice and snow sports, the company actively promoted ice and snow projects, successfully developed self-lubricating simulated ice rinks, indoor simulated ski machines, and other ice and snow series products, receiving unanimous recognition from all sectors of the market. In the future, the company will also take national policies as its guidance, actively promote the sales of its ice and snow series products, and continue to play a positive leading and exemplary role in the promotion and popularization of ice and snow projects, encouraging more people to participate.
Impulse(Qingdao)Health Tech (002899.SZ): Offers movable cage football sports facilities, football goals and other supporting products.
Gelonghui December 18丨Impulse(Qingdao)Health Tech (002899.SZ) stated on the investor interaction platform that the company has movable cage football sports facilities, as well as supporting products like football goals.
Impulse(Qingdao)Health Tech (002899.SZ): The main growth points in the fourth quarter of 2024 are in the Americas and the Middle East, while growth in Europe is relatively stable.
On December 17, Glonghui reported that Impulse(Qingdao)Health Tech (002899.SZ) recently stated in its investor relations activities that the main growth points in the fourth quarter of 2024 will be in the Americas and the Middle East, with stable growth in Europe. In 2025, the key focus areas will still be Bullish on the Americas, the Middle East, and Europe. In these markets, the company will increase its investment in exhibitions, client visits, and social media to promote the sales of its own brand products.
Impulse(Qingdao)Health Tech (002899.SZ): Some customers have already achieved sales on the product side, and order volumes will increase starting next year.
On December 17, Longhui reported that Impulse(Qingdao)Health Tech (002899.SZ) recently stated in an investor relations activity that, along with the upcoming release of production capacity at the company's ShenZhen New Industries Biomedical Engineering park, the company has begun to expand its layout for new customers. Some customers have already achieved sales on the product side, and starting next year, the order volume will see some growth; additionally, the company is actively negotiating cooperation matters with some customers.
Impulse(Qingdao)Health Tech (002899.SZ): Currently, there are no plans for overseas investment to establish factories.
Gelonghui reported on December 16 that Impulse(Qingdao)Health Tech (002899.SZ) stated on the investor interaction platform that the company currently has no plans for overseas factory investment. If there are any related plans in the future, the company will fulfill its information disclosure obligations in a timely manner, and please pay attention to the company's follow-up developments.